TGFB1 and breast carcinoma: This suggests that focusing on ppGalNAc-T4 may hold promise as a therapeutic strategy for breast cancer.118 Together, these studies suggested the regulatory role of glycosylation in TGF-β signaling, more investigations are needed to better understand the process and its implications.